Sunesis Pharmaceuticals To Present Data At The AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS), a clinical-stage biopharmaceutical company developing novel anticancer therapeutics, announced that the company will present data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. This year’s conference will be held October 22-26, 2007 in San Francisco, California. [click link for full article]
More: continued here
Filed under: Cancer on October 20th, 2007